Free Newsletter
FDA pushed 'voluntary' cold-meds change
You know last week's voluntary warning on cold meds for kids under four? Turns out that it wasn't so voluntary. According to the Associated Press, the FDA pushed drugmakers to warn against using the OTC drugs in young children. And the four-year-old cut-off appears to have been a compromise proposed by FDA in behind-the-scenes talks with the companies involved.
A panel of FDA advisers last year suggested that the threshold should be six years. And some of those advisers weren't happy with last week's move. "There was no data suggesting that the drugs were effective in kids under 12," one expert adviser told the AP. And, as the news service points out, ER data shows that the meds sicken about 7,000 kids a year, mostly because of overdoses.
As you know, pediatricians have been lobbying the FDA to ban the cold products for kids under six, and an agency advisory panel agreed. But the FDA itself made the under-four suggestion instead.
- see the Health Blog post
- check out the story from the Associated Press
Related Articles:
No more cold meds for kids under four
FDA to revamp rules on kids' cold meds
FDA experts mull ban on child cold meds
Drugmakers recall infant cold meds
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: